Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators.

Collimator Heart-to-mediastinum ratio Linear conversion MIBG

Journal

EJNMMI physics
ISSN: 2197-7364
Titre abrégé: EJNMMI Phys
Pays: Germany
ID NLM: 101658952

Informations de publication

Date de publication:
23 Jul 2019
Historique:
received: 06 03 2019
accepted: 15 07 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 25 7 2019
Statut: epublish

Résumé

The heart-to-mediastinum (H/M) ratio is a commonly used parameter to measure cardiac I-123 metaiodobenzylguanidine (MIBG) uptake. Since the H/M ratio is substantially influenced by the collimator type, we investigated whether an empirical linear conversion of H/M ratios between camera systems with low-energy (LE) and medium-energy (ME) collimator is possible. We included 18 patients with parkinsonism who were referred to one of the two participating molecular imaging facilities for the evaluation of cardiac sympathetic innervation by MIBG scintigraphy. Two consecutive planar image datasets were acquired with LE and ME collimators at 4 h after MIBG administration. Linear regression analyses were performed to describe the association between the H/M ratios gained with both collimator settings, and the accuracy of a linear transfer of the H/M ratio between collimators and across centers was assessed using a leave-one-out procedure. H/M ratios acquired with LE and ME collimators showed a strong linear relationship both within each imaging facility (R The present study demonstrates that a simple linear conversion of H/M ratios acquired with different collimators is possible with high accuracy. This should greatly facilitate the exchange of normative data between settings and pooling of data from different institutions.

Sections du résumé

BACKGROUND BACKGROUND
The heart-to-mediastinum (H/M) ratio is a commonly used parameter to measure cardiac I-123 metaiodobenzylguanidine (MIBG) uptake. Since the H/M ratio is substantially influenced by the collimator type, we investigated whether an empirical linear conversion of H/M ratios between camera systems with low-energy (LE) and medium-energy (ME) collimator is possible.
METHODS METHODS
We included 18 patients with parkinsonism who were referred to one of the two participating molecular imaging facilities for the evaluation of cardiac sympathetic innervation by MIBG scintigraphy. Two consecutive planar image datasets were acquired with LE and ME collimators at 4 h after MIBG administration. Linear regression analyses were performed to describe the association between the H/M ratios gained with both collimator settings, and the accuracy of a linear transfer of the H/M ratio between collimators and across centers was assessed using a leave-one-out procedure.
RESULTS RESULTS
H/M ratios acquired with LE and ME collimators showed a strong linear relationship both within each imaging facility (R
CONCLUSIONS CONCLUSIONS
The present study demonstrates that a simple linear conversion of H/M ratios acquired with different collimators is possible with high accuracy. This should greatly facilitate the exchange of normative data between settings and pooling of data from different institutions.

Identifiants

pubmed: 31338697
doi: 10.1186/s40658-019-0250-2
pii: 10.1186/s40658-019-0250-2
pmc: PMC6650508
doi:

Types de publication

Journal Article

Langues

eng

Pagination

12

Références

Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1100-7
pubmed: 15902438
Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):547-53
pubmed: 17922122
J Am Coll Cardiol. 2010 May 18;55(20):2212-21
pubmed: 20188504
Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1802-12
pubmed: 20577740
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2436-46
pubmed: 20644928
J Neuroimaging. 2012 Apr;22(2):111-7
pubmed: 21091814
Mov Disord. 2011 Jun;26(7):1218-24
pubmed: 21480373
Clin Auton Res. 2012 Feb;22(1):43-55
pubmed: 21792729
Parkinsonism Relat Disord. 2012 Jun;18(5):494-500
pubmed: 22321865
J Nucl Med. 2013 May;54(5):707-13
pubmed: 23536225
J Nucl Cardiol. 2014 Jun;21(3):614-21
pubmed: 24715623
J Nucl Cardiol. 2014 Oct;21(5):970-8
pubmed: 24942608
J Nucl Cardiol. 2018 Aug;25(4):1191-1197
pubmed: 28120154
J Nucl Cardiol. 2018 Jan 17;:null
pubmed: 29344924
Circulation. 1988 Nov;78(5 Pt 1):1192-9
pubmed: 3180378
Psychol Rep. 1966 Aug;19(1):3-11
pubmed: 5942109
J Nucl Med. 1981 Jan;22(1):22-31
pubmed: 7452352

Auteurs

Joachim Brumberg (J)

Department of Nuclear Medicine, University Hospital Würzburg and Julius-Maximilians-University, Oberdürrbacher Straße 6, 97080, Würzburg, Germany. Brumberg_J@ukw.de.

Ganna Blazhenets (G)

Department of Nuclear Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg im Breisgau, Germany.

Nils Schröter (N)

Department of Neurology, Medical Center, Faculty of Medicine, University of Freiburg, Breisacher Straße 64, 79106, Freiburg im Breisgau, Germany.

Lars Frings (L)

Department of Nuclear Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg im Breisgau, Germany.
Center for Geriatrics and Gerontology Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Lehener Straße 88, 79106, Freiburg im Breisgau, Germany.

Wolfgang H Jost (WH)

Parkinson-Klinik Ortenau, Kreuzbergstraße 12, 77709, Wolfach, Germany.

Constantin Lapa (C)

Department of Nuclear Medicine, University Hospital Würzburg and Julius-Maximilians-University, Oberdürrbacher Straße 6, 97080, Würzburg, Germany.

Philipp T Meyer (PT)

Department of Nuclear Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg im Breisgau, Germany.

Classifications MeSH